Anees Malik

Anees Malik is a highly experienced professional in market access and strategy within the life sciences sector, currently serving as Director of International Market Access and Head of Northern Europe, Canada, and Australia at Alnylam Pharmaceuticals since September 2018. With a strong background in strategic planning, pricing, and market analysis, Malik previously held roles at Evaluate Ltd as Managing Analyst specializing in new product development, and at Sociable Pharma as Principal Analyst for immunology. Earlier experience includes leading advisory engagements at Decision Resources Group and consulting on cell and gene therapies at asklepian consulting. Malik's career began at Pfizer as a Business Development & Licensing Analyst. Educational qualifications include a Leadership Programme from Saïd Business School, University of Oxford, a Master's in Bioscience Enterprise from the University of Cambridge, and a Master's in Pharmacy from Aston University.